Feel Comfortable With Long-Acting Beta-Agonists Plus Inhaled Steroids for Asthma

February 2018

Labeling changes will bring questions about the role of long-acting beta-agonists (LABAs) for asthma.

We've heard about early studies that suggest using a LABA withOUT an inhaled corticosteroid (ICS) increases the risk of asthma death.

This led to FDA's boxed warning in 2003 to stop LABAs once asthma is controlled...and required manufacturers to study the safety of LABAs in combo with inhaled steroids.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Women's Health Ease Fears About Breast Cancer Risk With Hormonal Contraception
Supplements Be Aware That Biotin May Skew Lab Test Results
Cardiology Use "ABCDs" to Optimize Meds for Stable Coronary Artery Disease
Travel Medicine Save Meds for Patients at Moderate to High Risk of Altitude Sickness
Diabetes Meds Compare New GLP-1 Agonist and Flozin Options for Type 2 Diabetes
Monitoring Compare FreeStyle Libre and Other Continuous Glucose Monitors
Asthma Feel Comfortable With Long-Acting Beta-Agonists Plus Inhaled Steroids for Asthma
Psoriasis Know Key Points About Biologics for Your Patients With Psoriasis
HIV & AIDS Think About Juluca for HIV Patients Who Can't Tolerate Other Meds
Erectile Dysfunction Anticipate Interest in Generic Viagra (Sildenafil)
Practice Get Tools to Tackle This Flu Season

Feel Comfortable With Long-Acting Beta-Agonists Plus Inhaled Steroids for Asthma

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents